Environmental Science & Technology, 2024 OMICs Signatures Linking Persistent Organic Pollutants to Cardiovascular Disease in the Swedish Mammography Cohort Schillemans T., Yan Y., Ribbenstedt A. et al. Olink Target 96CVDEnvironmental Health & ToxicologyPathophysiologyPatient StratificationPlasma | | | | |
Circulation Research, 2024 Directional Endothelial Communication by Polarized Extracellular Vesicle Release Raju S., Botts S., Blaser M. et al. Olink Target 96CVDPathophysiologyCell Culture Supernatant | | | | |
Nature Biotechnology, 2024 Discovery of sparse, reliable omic biomarkers with Stabl Hédou J., Marić I., Bellan G. et al. Olink Explore 3072/384Wider Bioinformatics StudiesData SciencePlasma | | | | |
Journal of Crohn's and Colitis, 2023 Baseline Serum and Stool Microbiome Biomarkers Predict Clinical Efficacy and Tissue Molecular Response After Ritlecitinib Induction Therapy in Ulcerative Colitis Hassan-Zahraee M., Ye Z., Xi L. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPatient StratificationSerumTissue Lysate | | | | |
International Journal of Obesity, 2023 Sex-specific association of visceral and subcutaneous adipose tissue volumes with systemic inflammation and innate immune cells in people living with obesity van den Munckhof I., Bahrar H., Schraa K. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
Biomarkers, 2023 Relationships between Charlson comorbidity index associated biomarkers and outcomes among participants in the Malmö diet and cancer study Wessman T., Ruge T., Carlsson A. et al. Olink Target 96CVDPatient StratificationSerum | | | | |
Journal of Clinical Immunology, 2023 Plasma Levels of mir-34a-5p Correlate with Systemic Inflammation and Low Naïve CD4 T Cells in Common Variable Immunodeficiency Nyström S., Hultberg J., Blixt E. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
British Journal of Cancer, 2023 Associations of diabetes, circulating protein biomarkers, and risk of pancreatic cancer Pang Y., Lv J., Wu T. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Environmental Toxicology and Pharmacology, 2023 Inflammation-related proteins in blood after dermal exposure to some common chemicals depend on the skin barrier gene filaggrin - a human experimental study Liljedahl E., Gliga A., de Paula H. et al. Olink Target 96Environmental Health & ToxicologyPathophysiologySerum | | | | |
Blood Advances, 2023 A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204) Phillips T., Avigdor A., Gurion R. et al. Olink Target 96OncologyPathophysiologySerum | | | | |
Cancer Research Communications, 2023 Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study Munster P., Iannotti N., Cho D. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
eBioMedicine, 2023 Circulating biomarkers in familial cerebral cavernous malformation Lazzaroni F., Meessen J., Sun Y. et al. Olink Target 96Neurovascular DiseasesPatient StratificationPlasma | | | | |
Cancers, 2023 Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin–Progranulin Axis in Breast Cancer Berger K., Persson E., Gregersson P. et al. Olink Target 96OncologyPathophysiologyCell Culture Supernatant | | | | |
Nature, 2023 An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis LaMarche N., Hegde S., Park M. et al. Olink Target 96OncologyPathophysiologySerum | | | | |
Cardiology and Therapy, 2023 Dual-Pathway Inhibition with Rivaroxaban and Low-Dose Aspirin Does Not Alter Immune Cell Responsiveness and Distribution in Patients with Coronary Artery Disease Groh L., Willems L., Fintelman P. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Blood Advances, 2023 Clinical and immunological features in ACKR1/DARC-associated neutropenia Palmblad J., Sohlberg E., Nilsson C. et al. Olink Target 96HematologyPatient StratificationPlasma | | | | |
eBioMedicine, 2023 Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial Zhang X., Irajizad E., Hoffman K. et al. Olink Target 96OncologyNutritional SciencePathophysiologyPlasma | | | | |
Cancers, 2023 Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor Stensgaard S., Thomsen A., Helstrup S. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Scientific Reports, 2023 Changes in natural killer and T lymphocyte phenotypes in response to cardiovascular risk management Good E., Åkerman L., Nyström S. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Pediatric Research, 2023 Antisecretory factor in breastmilk is associated with reduced incidence of sepsis in preterm infants Gustafsson A., Johansson E., Henckel E. et al. Olink Target 96Infectious DiseasesObstetricsPathophysiologyPlasma | | | | |